ARCHIVES

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

No Cancer Letter For Two Weeks

August 10, 1990

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012